Exagen Inc.XGNNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank58
3Y CAGR-23.5%
5Y CAGR-23.9%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-23.5%/yr
vs -0.4%/yr prior
5Y CAGR
-23.9%/yr
Consistent
Acceleration
-23.1pp
Decelerating
Percentile
P58
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 16.35% |
| 2024 | 10.48% |
| 2023 | -50.74% |
| 2022 | 36.47% |
| 2021 | 102.83% |
| 2020 | 63.97% |
| 2019 | 2.40% |
| 2018 | 37.01% |
| 2017 | 0.00% |
| 2015 | 6.22% |